Conference abstract · 16 Nov 2015
Short communicationPublished 27 May 2016
High Altitude Brain Swelling
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The high-altitude (HA) environment generally refers to elevations over 1500 m (4800 feet) above sea level. High-altitude illnesses is the term given collectively to Acute Mountain Sickness (AMS), High-Altitude Cerebral Edema (HACE) and High-Altitude Pulmonary Edema (HAPE), the latter two being potentially fatal conditions. The complete pathophysiological mechanisms of these maladies are not completely known and their incidences are highly variable amongst different ethnic populations. Some individuals are able to acclimatize better and are genetically more resistant to HA conditions compare to others. The occurrence and severity of the disease is highly dependent on the rate of ascent, the altitude attained and individual susceptibility.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Sep 2020
Stroke and COVID 19 in high altitude Andean inhabitant
Conference abstract · 19 Jul 2016
Subcortical dementia developed at high altitude in Himalayas - an army case study investigation with MMSE and new UMACE diagnostic tool
Mini review · 7 Dec 2015
Travelling to High Altitudes Lead to Difficult Sleeping- Review
Conference abstract · 15 Nov 2018
Neuroprotective effects of nanodelivery of cerebrolysin with mesenchymal stem cells in high altitude induced exacerbation of brain injury
More from this journal
The newest in Journal of Neurology and Neuroscience.
Research article · 15 Jul 2025
Oral inhaled cromolyn for mild-to-moderate amyotrophic lateral sclerosis: A randomized, open label phase 2a study
Research article · 15 Jul 2025
Diffuse Intrinsic Pontine Glioma: Unusually Long Survival of 28 Patients (From 3 Years to Over 29 Years) in Phase 2 Studies with Antineoplastons A10 and AS2-1
Short communication · 24 Jun 2025
The Role of High-Pressure Balloon Angioplasty in Treating Intracranial Atherosclerosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neurology and Neuroscience
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Swati Srivastava”

